Translations of Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamid

LanguageTitleStatusOperations
Danishn/aNot translated
Dutchn/aNot translated
English (source)Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with ProxalutamidPublished
Frenchn/aNot translated
Germann/aNot translated
Italiann/aNot translated
Spanishn/aNot translated
Swahilin/aNot translated
Swedishn/aNot translated